Copyright: ©Author(s) 2026.
World J Transplant. Jun 18, 2026; 16(2): 118088
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.118088
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.118088
Table 7 Observed outcomes by biopsy status in the propensity-matched cohort, n (%)/median (interquartile rage)
| Outcome | Not biopsied (n = 26047) | Biopsied (n = 26047) | P value1 |
| Delayed graft function | 7177 (27.6) | 7957 (30.6) | < 0.001 |
| Serum creatinine mg/dL 6 months | 1.3 (1.1-1.7) | 1.4 (1.1-1.7) | < 0.001 |
| Serum creatinine mg/dL 12 months | 1.3 (1.1-1.6) | 1.4 (1.1-1.7) | < 0.001 |
- Citation: Sibulesky L, Kaufman DM, Bakthavatsalam R, Leca N, Perkins JD. Rethinking procurement biopsy in donors with normal renal function: A barrier to kidney utilization without survival benefit. World J Transplant 2026; 16(2): 118088
- URL: https://www.wjgnet.com/2220-3230/full/v16/i2/118088.htm
- DOI: https://dx.doi.org/10.5500/wjt.v16.i2.118088